针对非霍奇金淋巴瘤的新兴免疫疗法进展:利用T细胞进行抗击
Alexandra E Rojek1, Sonali M Smith1
1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
包括CAR T细胞和双特异性抗体在内的T细胞参与 (TCE) 疗法正在彻底改变B细胞非霍奇金淋巴瘤治疗. 创新旨在提高疗效,降低毒性,并扩大这些免疫疗法的获取.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- T细胞参与 (TCE) 疗法显著改变了B细胞非霍奇金淋巴瘤 (B-NHL) 的治疗方法.
- 抗CD19仿真抗原受体 (CAR) T细胞疗法现在已被批准用于各种复发/耐药B-NHL亚型,并正在进入早期治疗线.
- 针对CD20 × CD3的双特异性抗体也获得了针对复发/耐药B-NHL的单疗法的批准.
研究的目的:
- 审查B-NHL的TCE疗法的最新策略和创新.
- 讨论早期治疗整合,组合方法和TCE疗法的测序等正在进行的研究.
- 为突出改善TCE治疗疗效,安全和后勤交付的努力.
主要方法:
- 对B-NHL中TCE疗法的当前文献和临床试验数据的审查.
- 对CAR T细胞和双特异性抗体探索新目标和工程策略.
- 讨论制造业的进步,T细胞优化和安全概况.
主要成果:
- 包括CAR T细胞和双特异性抗体在内的TCE疗法在B-NHL中表现出显著的疗效.
- 目前正在进行的研究重点是优化治疗模式,例如早期使用和组合策略.
- 目前正在开发技术创新,以提高疗效,降低毒性,提高治疗可及性.
结论:
- TCE疗法正在成为B-NHL免疫疗法的支柱,持续的进展有望得到更广泛的应用.
- 需要进行进一步的研究,以克服广泛获取和优化患者治疗结果的剩余障碍.
- 在CAR T细胞设计,制造和双特异性抗体开发方面的创新对于B-NHL治疗的未来至关重要.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:30Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K